Moreover, the conventional approach usually relies on the p value and fold change to determine whether a feature is significant, which would neglect glycoprotein changes that do not show significance in the group comparison but may still play a biological role in one or more subtypes of pancreatic cancers. This evidence concerns the gene ART4 and familial pancreatic carcinoma.